AstraZeneca has entered an agreement to partner with VaxEquity to discover, develop and market the proprietary self-amplifying ribonucleic acid (saRNA) therapeutics platform created at Imperial College London in the UK. The strategic, long-term research partnership […]
Sanofi has concluded the acquisition of messenger RNA (mRNA) therapies company, Translate Bio, for $38 per share in cash, representing a total equity value of nearly $3.2bn, on a fully diluted basis. Last month, Sanofi […]
AbCellera and Everest Medicines have signed a multi-year partnership and license agreement to discover therapeutic antibodies for up to ten targets selected by the latter. The collaboration will aid in growing Everest’s portfolio of new […]
The research partnership between Tonix Pharmaceuticals and Columbia University in the US has been extended to serve the development of Covid-19 vaccines and therapies precision treatment techniques. Additionally, Tonix Pharmaceuticals and Columbia University will analyse […]
Johnson & Johnson (J&J) has reported the latest data confirming the robust and durable protection provided by its Janssen Covid-19 vaccine. The single-shot vaccine is authorised under a US Food and Drug Administration (FDA) Emergency […]